Probably sage words, thanks
Yes can definitely weigh but generally effects companies more when there is no medium term inflection points on the horizon.
In terms of market cap I just can’t see it dropping too much further. Having said that (and what I said) I already have a fairly decent (for me) position in the company and while I think I will still accumulate more it will be in a fairly patient kind of way.
- Forums
- ASX - By Stock
- DLM
- Ann: Clinical Trial Update
Ann: Clinical Trial Update, page-14
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online